Skip to content

Hangzhou Tigermed Consulting Co Ltd Sustainability Reports

The company operates as a clinical Contract Research Organization (CRO) that provides comprehensive research and development services for the biopharmaceutical and medical device industries. Its offerings span across preclinical development, clinical trials, and clinical research consulting services.

Sector: Professional & technical services

Country: China

Exchange: Shenzhen Stock Exchange

ISIN: CNE100001KV8

13 reports from 2018 to 2025